Reducing Risk in Decentralized Trials with Digital Automation: Part 2 - Automate, then Practice
In Part 1 of this series on Reducing Risk in Decentralized Trials, we covered 7 key issues that...
No video selected
Select a video type in the sidebar.
In Part 1 of this series on Reducing Risk in Decentralized Trials, we covered 7 key issues that...
Interest in decentralized clinical trials (DCTs) is now full steam ahead – and so is the confusion....
We know clinical trials are vital for developing new medicines, medical devices, and diagnostic...
I am old enough to remember the days before caller ID when poor souls would simply pick up every...
Jennifer Byrne, CEO of Javara, sat down with ProofPilot to discuss how to harmonize clinical...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Since 1999, I have been trying to crack the nut of how to scale physician referrals as a successful...
On a recent Diligent Pharma Webinar, Joseph Kim, Chief Strategy Officer of ProofPilot, covered 7...